Medicine packaging

Since 2001, EU rules have required the medicines we buy in the EU to contain a package leaflet which should provide us – the user, with clear information on the medicines we are taking – including the name of the product and the manufacturer, therapeutic indications, dosage, shelf life and adverse reactions.

The Commission has recently put forward recommendations on how they could be improved to better meet the needs of patients and healthcare professionals.

To read the recommendations on improved medicine packaging on the ec.europa.eu website